Cannabidiol Market Size, Share, Growth Dynamics, Revenue Outlook and Opportunities Forecast 2021 - 2028
Cannabidiol Market |
Cannabidiol (CBD) is one of 113 cannabinoids found in marijuana plants, accounting for up to 40% of the plant's extract. It's the second most common active component in marijuana (marijuana). CBD is often used to treat anxiety and to help people who are suffering from insomnia. CBD oil is utilised in a variety of medical applications, including anxiety and depression treatment, stress relief, diabetes prevention, pain relief, cancer symptom relief, and acne reduction.
Although favourable legislation for the use of cannabis and related goods are continuously being provided from a number of places, the majority of regions still have strict regulatory presence regulating its use. Furthermore, in growing countries of the world such as Latin America, East Asia, Europe, and others, there is a lack of information and awareness about the numerous benefits, which can limit the Cannabidiol Market growth.
There is a growing need for nutrient-dense foods to help people achieve their fitness objectives and avoid problems like inflammation and pain. The introduction of CBD-infused goods is a priority for major industry players. CBD oil is a nonpsychoactive and legal component of hemp that can be used in a variety of industries, including food, health products, pharmaceuticals, and cosmetics. CBD, for example, is frequently used to treat a variety of health issues such as sleeplessness and anxiety, according to data from the Harvard Health Institute from 2018.
Market Segmentation:
By Product
- Oil
- Tinctures
- Suppository
- Transdermal Patches
- Vape Oil
- Isolates
- Creams and Roll-on
- Capsules
- Tablet
- Others
By Source Type
- Hemp
- Marijuana
By Application
- Medical
- Personal Use
- Pharmaceuticals
- Wellness
By Distribution Channel
- Hospital Pharmacies
- Online Stores
- Retail Stores
The major players operating in the global cannabidiol market include Canopy Growth Corporation, Aphria, Inc., Aurora Cannabis, Maricann, Inc. (Wayland Group Corporation), Tilray, GW Pharmaceuticals, plc, ABcann Medicinals, Inc., Organigram Holding, Inc., Tikun Olam, The Cronos Group, ENDOCA, Isodiol International, Inc., MEDICAL MARIJUANA, INC., Cannoid, LLC, Elixinol, Folium Biosciences, NuLeaf Naturals, LLC, and Pharmahemp d.o.o.
Comments
Post a Comment